Stratification of the Lin−CD34bright into defined populations of HSPCs revealed that CD235a was highly over-expressed in the HMCs, MPPs, and HSCs of SCD patients in all three treatment groups and somewhat less so in the HPCs, CMPs, and GMPs (Figure 4B,C). The gene discussed is GYPA; the disease is Schnyder corneal dystrophy.